Abstract
We present long-term results of a phase II trial of induction chemotherapy (IC) with uracilftegafur (UFT) 200 mg/m orally days 1 to 21, vinorelbine 25 mg/m intravenously (IV) days 1 and 8, and cisplatin 100 mg/m IV day 1 (UFTVP) each for 21 days for 4 courses, followed by radiotherapy concomitant with UFT 100 mg/m orally daily and carboplatin (area under the curve [AUC] = 0.5 IV weekly) (RT/ UFTJ), without surgery to the primary site if response, in patients (pts) with resectable locally advanced squamous cell carcinoma of the larynx and hypopharynx. The primary endpoint was clinical complete response (CR) to induction UFTVP, and secondary endpoints were long-term overall survival (OS) and survival with primary site preservation (SPP). Between 1994 and 1997, 37 pts were included. CR to IC was 54% (95% confidence interval [CI] 43-65%). Main toxicity of UFTVP was G 3,4 neutropenia (73% of pts, 16% developed febrile neutropenia). After IC, primary site was treated with RT in 29 pts: 20 of them received RT/UFTJ (main toxicity mucositis G 3,4 70%). No pt died during treatment. Actuarial 5-year OS and SPP were 57% and 37%, respectively. This approach has significant activity and acceptable toxicity for achieving promising long-term O...Continue Reading
References
Jun 13, 1991·The New England Journal of Medicine·UNKNOWN Department of Veterans Affairs Laryngeal Cancer Study GroupWilliam G Henderson
Aug 1, 1990·Cancer·M A ListS B Lansky
May 1, 1984·Cancer·J A KishM Al-Sarraf
Aug 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M B SpauldingG T Wolf
Nov 1, 1993·Oncology·T SchnabelG Schmitt
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V GebbiaN Gebbia
Jan 1, 1993·Clinical Oncology : a Journal of the Royal College of Radiologists·S P AcklandJ W Denham
Jan 21, 1993·The New England Journal of Medicine·E E VokesW K Hong
Jul 3, 1996·Journal of the National Cancer Institute·J L LefebvreT Sahmoud
Dec 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V GebbiaB Ferrero
Sep 19, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J R ClarkM R Posner
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A D ColevasM R Posner
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M S KiesE E Vokes
Mar 11, 2000·Drugs·B E Brockstein, E E Vokes
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M R PosnerC A Garay
Jan 5, 2002·The New England Journal of Medicine·A ForastiereD Sidransky
Citations
Sep 29, 2007·Cancer Chemotherapy and Pharmacology·Fernando RiveraJaime Sanz-Ortiz
Apr 24, 2009·International Journal of Radiation Oncology, Biology, Physics·Melanie FesneauGilles Calais
Aug 4, 2007·Cancer Letters·Pol M Specenier, Jan B Vermorken
Sep 2, 2006·The Lancet Oncology·Jean Louis Lefebvre